Industry: Chemical & Material
Published Date: 2026-07-09
Pages: 149 Pages
Report ld: 6828607
Request Sample
Customized Report
The global market for Antiblocking Agents was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Antiblocking Agents cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Asia-Pacific is expected to experience the highest growth in the market during the forecast period.
This report provides a comprehensive view of the global market for Antiblocking Agents, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Antiblocking Agents market size, estimations, and forecasts are presented in terms of sales volume (Kiloton) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Antiblocking Agents.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Antiblocking Agents manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Antiblocking Agents sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Antiblocking Agents sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Antiblocking Agents Product Introduction
1.2 Global Antiblocking Agents Market Size Forecast
1.2.1 Global Antiblocking Agents Sales Value (2021–2032)
1.2.2 Global Antiblocking Agents Sales Volume (2021–2032)
1.2.3 Global Antiblocking Agents Sales Price (2021–2032)
1.3 Antiblocking Agents Market Trends & Drivers
1.3.1 Antiblocking Agents Industry Trends
1.3.2 Antiblocking Agents Market Drivers & Opportunities
1.3.3 Antiblocking Agents Market Challenges
1.3.4 Antiblocking Agents Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antiblocking Agents Players Revenue Ranking (2025)
2.2 Global Antiblocking Agents Revenue by Company (2021–2026)
2.3 Global Antiblocking Agents Sales Volume Ranking of Players (2025)
2.4 Global Antiblocking Agents Sales Volume by Company (2021–2026)
2.5 Global Antiblocking Agents Average Price by Company (2021–2026)
2.6 Key Manufacturers Antiblocking Agents Manufacturing Base and Headquarters
2.7 Key Manufacturers Antiblocking Agents Product Offerings
2.8 Key Manufacturers Start of Mass Production of Antiblocking Agents
2.9 Antiblocking Agents Market Competitive Analysis
2.9.1 Antiblocking Agents Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Antiblocking Agents Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antiblocking Agents revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Antiblocking Agents Market Classification
3.1 Introduction by Type
3.1.1 Organic
3.1.2 Inorganic
3.1.3 Global Antiblocking Agents Sales Value by Type
3.1.3.1 Global Antiblocking Agents Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Antiblocking Agents Sales Value, by Type (2021–2032)
3.1.3.3 Global Antiblocking Agents Sales Value, by Type (%), 2021–2032
3.1.4 Global Antiblocking Agents Sales Volume by Type
3.1.4.1 Global Antiblocking Agents Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Antiblocking Agents Sales Volume, by Type (2021–2032)
3.1.4.3 Global Antiblocking Agents Sales Volume, by Type (%), 2021–2032
3.1.5 Global Antiblocking Agents Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 PE Films
4.1.2 PP Films
4.1.3 Others
4.2 Global Antiblocking Agents Sales Value by Application
4.2.1 Global Antiblocking Agents Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Antiblocking Agents Sales Value, by Application (2021–2032)
4.2.3 Global Antiblocking Agents Sales Value, by Application (%), 2021–2032
4.3 Global Antiblocking Agents Sales Volume by Application
4.3.1 Global Antiblocking Agents Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Antiblocking Agents Sales Volume, by Application (2021–2032)
4.3.3 Global Antiblocking Agents Sales Volume, by Application (%), 2021–2032
4.4 Global Antiblocking Agents Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Antiblocking Agents Sales Value by Region
5.1.1 Global Antiblocking Agents Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Antiblocking Agents Sales Value by Region (2021–2026)
5.1.3 Global Antiblocking Agents Sales Value by Region (2027–2032)
5.1.4 Global Antiblocking Agents Sales Value by Region (%), 2021–2032
5.2 Global Antiblocking Agents Sales Volume by Region
5.2.1 Global Antiblocking Agents Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Antiblocking Agents Sales Volume by Region (2021–2026)
5.2.3 Global Antiblocking Agents Sales Volume by Region (2027–2032)
5.2.4 Global Antiblocking Agents Sales Volume by Region (%), 2021–2032
5.3 Global Antiblocking Agents Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Antiblocking Agents Sales Value, 2021–2032
5.4.2 North America Antiblocking Agents Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Antiblocking Agents Sales Value, 2021–2032
5.5.2 Europe Antiblocking Agents Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Antiblocking Agents Sales Value, 2021–2032
5.6.2 Asia Pacific Antiblocking Agents Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Antiblocking Agents Sales Value, 2021–2032
5.7.2 South America Antiblocking Agents Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antiblocking Agents Sales Value, 2021–2032
5.8.2 Middle East & Africa Antiblocking Agents Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antiblocking Agents Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Antiblocking Agents Sales Value and Sales Volume
6.2.1 Key Countries/Regions Antiblocking Agents Sales Value, 2021–2032
6.2.2 Key Countries/Regions Antiblocking Agents Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Antiblocking Agents Sales Value, 2021–2032
6.3.2 United States Antiblocking Agents Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Antiblocking Agents Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Antiblocking Agents Sales Value, 2021–2032
6.4.2 Europe Antiblocking Agents Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Antiblocking Agents Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Antiblocking Agents Sales Value, 2021–2032
6.5.2 China Antiblocking Agents Sales Value by Type (%), 2025 vs 2032
6.5.3 China Antiblocking Agents Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Antiblocking Agents Sales Value, 2021–2032
6.6.2 Japan Antiblocking Agents Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Antiblocking Agents Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Antiblocking Agents Sales Value, 2021–2032
6.7.2 South Korea Antiblocking Agents Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Antiblocking Agents Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Antiblocking Agents Sales Value, 2021–2032
6.8.2 Southeast Asia Antiblocking Agents Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Antiblocking Agents Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Antiblocking Agents Sales Value, 2021–2032
6.9.2 India Antiblocking Agents Sales Value by Type (%), 2025 vs 2032
6.9.3 India Antiblocking Agents Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Evonik
7.1.1 Evonik Company Information
7.1.2 Evonik Introduction and Business Overview
7.1.3 Evonik Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Evonik Antiblocking Agents Product Offerings
7.1.5 Evonik Recent Developments
7.2 WR Grace
7.2.1 WR Grace Company Information
7.2.2 WR Grace Introduction and Business Overview
7.2.3 WR Grace Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 WR Grace Antiblocking Agents Product Offerings
7.2.5 WR Grace Recent Developments
7.3 Minerals Technologies
7.3.1 Minerals Technologies Company Information
7.3.2 Minerals Technologies Introduction and Business Overview
7.3.3 Minerals Technologies Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Minerals Technologies Antiblocking Agents Product Offerings
7.3.5 Minerals Technologies Recent Developments
7.4 Croda
7.4.1 Croda Company Information
7.4.2 Croda Introduction and Business Overview
7.4.3 Croda Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Croda Antiblocking Agents Product Offerings
7.4.5 Croda Recent Developments
7.5 PQ Corporation
7.5.1 PQ Corporation Company Information
7.5.2 PQ Corporation Introduction and Business Overview
7.5.3 PQ Corporation Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 PQ Corporation Antiblocking Agents Product Offerings
7.5.5 PQ Corporation Recent Developments
7.6 Madhu Silica
7.6.1 Madhu Silica Company Information
7.6.2 Madhu Silica Introduction and Business Overview
7.6.3 Madhu Silica Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Madhu Silica Antiblocking Agents Product Offerings
7.6.5 Madhu Silica Recent Developments
7.7 Solvay
7.7.1 Solvay Company Information
7.7.2 Solvay Introduction and Business Overview
7.7.3 Solvay Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Solvay Antiblocking Agents Product Offerings
7.7.5 Solvay Recent Developments
7.8 Fuji Silysia
7.8.1 Fuji Silysia Company Information
7.8.2 Fuji Silysia Introduction and Business Overview
7.8.3 Fuji Silysia Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Fuji Silysia Antiblocking Agents Product Offerings
7.8.5 Fuji Silysia Recent Developments
7.9 IQE Group
7.9.1 IQE Group Company Information
7.9.2 IQE Group Introduction and Business Overview
7.9.3 IQE Group Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 IQE Group Antiblocking Agents Product Offerings
7.9.5 IQE Group Recent Developments
7.10 Tosoh Silica
7.10.1 Tosoh Silica Company Information
7.10.2 Tosoh Silica Introduction and Business Overview
7.10.3 Tosoh Silica Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Tosoh Silica Antiblocking Agents Product Offerings
7.10.5 Tosoh Silica Recent Developments
7.11 NYACOL Nano Technologies
7.11.1 NYACOL Nano Technologies Company Information
7.11.2 NYACOL Nano Technologies Introduction and Business Overview
7.11.3 NYACOL Nano Technologies Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 NYACOL Nano Technologies Antiblocking Agents Product Offerings
7.11.5 NYACOL Nano Technologies Recent Developments
7.12 S-Chemtech
7.12.1 S-Chemtech Company Information
7.12.2 S-Chemtech Introduction and Business Overview
7.12.3 S-Chemtech Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 S-Chemtech Antiblocking Agents Product Offerings
7.12.5 S-Chemtech Recent Developments
7.13 Baerlocher
7.13.1 Baerlocher Company Information
7.13.2 Baerlocher Introduction and Business Overview
7.13.3 Baerlocher Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Baerlocher Antiblocking Agents Product Offerings
7.13.5 Baerlocher Recent Developments
7.14 Imerys
7.14.1 Imerys Company Information
7.14.2 Imerys Introduction and Business Overview
7.14.3 Imerys Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Imerys Antiblocking Agents Product Offerings
7.14.5 Imerys Recent Developments
7.15 Hoffmann Mineral
7.15.1 Hoffmann Mineral Company Information
7.15.2 Hoffmann Mineral Introduction and Business Overview
7.15.3 Hoffmann Mineral Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Hoffmann Mineral Antiblocking Agents Product Offerings
7.15.5 Hoffmann Mineral Recent Developments
7.16 EP Mineral
7.16.1 EP Mineral Company Information
7.16.2 EP Mineral Introduction and Business Overview
7.16.3 EP Mineral Antiblocking Agents Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 EP Mineral Antiblocking Agents Product Offerings
7.16.5 EP Mineral Recent Developments
8 Industry Chain Analysis
8.1 Antiblocking Agents Industrial Chain
8.2 Antiblocking Agents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Antiblocking Agents Sales Model
8.5.2 Sales Channels
8.5.3 Antiblocking Agents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Antiblocking Agents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 148
USD 2900.00
(Single User License)
The global Antiblocking Agents market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-24
Pages: 179
USD 4900.00
(Single User License)
The global Antiblocking Agents market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 101
USD 4250.00
(Single User License)
The global market for Antiblocking Agents was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 138
USD 3950.00
(Single User License)
The global market for Antiblocking Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 115
USD 2900.00
(Single User License)
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published Date: 2024-04-08
Pages: 115
USD 4900.00
(Single User License)
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published Date: 2024-02-22
Pages: 142
USD 3950.00
(Single User License)
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published Date: 2024-01-16
Pages: 114
USD 2900.00
(Single User License)
The global Antiblocking Agents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 148
The global Antiblocking Agents market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-24
Pages: 179
The global Antiblocking Agents market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 101
The global market for Antiblocking Agents was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 138
The global market for Antiblocking Agents was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 115
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published: 2024-04-08
Pages: 115
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published: 2024-02-22
Pages: 142
Anti-blocking agent is commonly used in the production and preparation of plastic film products, which can effectively improve the opening performance of the film. The earliest anti-blocking agent is inorganic talcum powder, diatomite, etc.
Published: 2024-01-16
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now